CluePoints
Current
“Summit’s combined experience in both life sciences and technology was highly relevant and extremely beneficial to CluePoints. With the Summit team’s active support – both strategic and tactical – we were able to accelerate product development and go-to-market expansion during a pivotal period in our company’s evolution.”
ARR growth during Summit’s investment
Employee headcount growth
Platform users
Studies de-risked since founding, detecting 142K+ issues
ARR growth during Summit’s investment
Employee headcount growth
Platform users
Studies de-risked since founding, detecting 142K+ issues
CluePoints was founded in 2012 with a vision to provide pharmaceutical companies and CROs a better way of identifying, visualizing, managing and documenting risks that could impact the outcome of clinical trials. The company’s cloud-based Risk-Based Quality Management (“RBQM”) solutions help sponsors remotely monitor clinical and operational data in real-time to increase efficiency, improve patient safety, and reduce costs. By 2020, CluePoints was seen as an established leader in RBQM, and the Co-founders sought a partner with deep experience scaling healthcare software businesses to support the company’s continued growth and global expansion to meet accelerating customer demand worldwide.
How Summit Partners Helped
- Led a minority investment in 2020
- Collaborated with management to accelerate investments in go-to-market and product development, supporting the development and launch of several new products that allowed CluePoints to diversify into new markets.
- Supported the company’s continued innovation in RBQM, as CluePoints introduced machine learning into both core and new products to help drive enhanced efficiency, speed and accuracy for customers
- Worked with management to accelerate global expansion, including helping to build out and modernize the company’s sales force in the United States, Europe and Japan
- Assisted in establishing a Customer Success team and rolling out best practices
- Worked closely with the founding team to actively support the recruitment of and transition to a new CEO and a CFO, each with deep experience in growing SaaS businesses
- Summit’s Technologist-in-Residence provided coaching to Engineering and Product Development teams on organizational design, which helped to attract talent and increase process efficiency
- Helped implement financial and KPI reporting best practices to support the CluePoints’ team in making data-driven, real-time operational decisions
Since Summit’s investment, CluePoints has generated strong growth, driven by accelerated product development efforts, including the launch of new SaaS-based products that incorporate machine learning and are designed to align with the company’s strategy of building an integrated, central data analytics platform for RBQM, medical and safety review and clinical trial data management. The company has earned significant industry recognition for its continued innovation in RBQM, including a Citeline Award for Excellence in Innovation in Response to COVID-19, as well as SCRIP Awards for Clinical Advance of the Year and Best Specialist Provider.
To read more about Summit’s experience in the life sciences sector, please see here.
The Portfolio Company Executive quoted herein did not receive compensation for any statements regarding Summit Partners. However, since CluePoints is a current portfolio company of Summit, this individual receives general compensation in connection with his employment by the company. In addition, this individual is not an investor in a Summit fund but may have conflicts arising from his role with CluePoints due to the company’s relationship with Summit.
Further, the industry recognition noted herein is the opinion of the party conferring the rating and not of Summit Partners. There can be no assurance that other providers or surveys would reach the same conclusion as the party conferring the rating referenced herein.
Related News
Get the Latest from Summit Partners
Subscribe to our newsletter to stay up to date on our partners, portfolio, and more.